Skip to main navigation

Patients & Families
Healthcare Providers
Investors & Media

Our Science
Our Pipeline
Our Company
Our Partnerships
Life at C4T

Our Science
Our Pipeline
- Overview
- Cemsidomide
- CFT8634
- CFT1946
- CFT8919
Our Partnerships
Who We Are
Life at C4T

Patients & Families
Healthcare Providers
Investors & Media

Overview
Press Releases
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Email Alerts
Contact IR
FAQs

Overview

Featured Menu

Our Corporate Presentation
Our Latest 10-K
Our Scientific Publications
Sign up for email alerts

Press Releases

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

Dec 8, 2024

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Nov 20, 2024

C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial

Nov 6, 2024

View All News

View all press releases

Upcoming Events

More events are coming soon.

Past Events

Updated Data in Multiple Myeloma and First Data in non-Hodgkin’s Lymphoma from the Ongoing Phase 1/2 Trial of Cemsidomide Presented at ASH 2024

Dec 8, 2024 5:00 PM EST

Supporting Materials

Cemsidomide Phase 1 Dose Escalation Data in MM and NHL 1.7 MB

Jefferies London Healthcare Conference

Nov 20, 2024 4:00 AM EST

2024 Cantor Global Healthcare Conference

Sep 18, 2024 8:35 AM EDT

View all events

View all of our past events

Change

Volume

52 Week High

52 Week Low

Dec 21, 2024 7:11 AM EST

Image Description

617-231-0700
info@c4therapeutics.com

490 Arsenal Way, Suite 120
Watertown, MA 02472

© 2024 C4 Therapeutics, Inc., Inc.

Privacy Policy
Terms of Use Agreement

You are now leaving c4therapeutics.com

You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.

No, I want to stay Yes, I want to Proceed to the Other Site

You are now leaving c4therapeutics.com

You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.

No, I want to stay Yes, I want to Proceed to the Other Site